Catamount Wealth Management’s Boston Scientific BSX Stock Holding History

Catamount Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$115K	Hold	3,000	–	–	0.07%	61
2018 Q4	$114K	Hold	3,000	–	–	0.08%	51
2018 Q3	$116K	Hold	3,000	–	–	0.06%	58
2018 Q2	$101K	Hold	3,000	–	–	0.05%	55
2018 Q1	$82K	Hold	3,000	–	–	0.04%	61
2017 Q4	$74K	Hold	3,000	–	–	0.04%	65
2017 Q3	$88K	Hold	3,000	–	–	0.05%	53
2017 Q2	$83K	Hold	3,000	–	–	0.05%	66
2017 Q1	$75K	Sell	3,000 -1,000	-25%	-$24.3K	0.05%	64
2016 Q4	$87K	Hold	4,000	–	–	0.07%	53
2016 Q3	$94K	Hold	4,000	–	–	0.08%	48
2016 Q2	$93K	Hold	4,000	–	–	0.11%	34
2016 Q1	$75K	Hold	4,000	–	–	0.09%	39
2015 Q4	$74K	Sell	4,000 -3,973	-50%	-$71.2K	0.07%	40
2015 Q3	$131K	Sell	7,973 -1,000	-11%	-$17.1K	0.13%	23
2015 Q2	$159K	Hold	8,973	–	–	0.12%	33
2015 Q1	$159K	Hold	8,973	–	–	0.13%	33
2014 Q4	$119K	Buy	+8,973	New	+$115K	0.11%	34

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Catamount Wealth Management's BSX Position: Q1 2019 in Review

Catamount Wealth Management held its Boston Scientific (BSX) position steady in Q1 2019 at 3,000 shares worth $115K. The position accounts for 0.07% of the portfolio, ranked #61.

Catamount Wealth Management first reported a position in BSX in Q4 2014 and has held it in 18 quarters since. The position peaked at $159K in Q2 2015. 789 funds tracked by Wall St. Rank hold BSX as of Q1 2019.

Catamount Wealth Management held 3,000 shares of Boston Scientific worth $115K as of Q1 2019.
Catamount Wealth Management left its Boston Scientific share count unchanged in Q1 2019.
Boston Scientific made up 0.07% of Catamount Wealth Management's portfolio in Q1 2019, its #61 holding.
Catamount Wealth Management first reported a position in Boston Scientific in Q4 2014 and has held it in 18 quarters since.
Catamount Wealth Management's Boston Scientific position peaked at $159K in Q2 2015.
789 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2019.

Based on Catamount Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.